• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

研究血管内皮生长因子受体-2(VEGFR-2)在脑胶质瘤微血管内皮细胞膜上的分布和密度。

A study of the distribution and density of the VEGFR-2 receptor on glioma microvascular endothelial cell membranes.

机构信息

Department of Neurosurgery, Guangdong Academy of Medical Sciences, Guangdong General Hospital & Guangdong Institute of Neuroscience, Guangzhou, China.

出版信息

Cell Mol Neurobiol. 2011 Jul;31(5):687-94. doi: 10.1007/s10571-011-9665-6. Epub 2011 Mar 9.

DOI:10.1007/s10571-011-9665-6
PMID:21547490
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11498356/
Abstract

The purpose of the study was to examine the nanoscale distribution and density of the VEGFR-2 membrane receptor on the endothelial cell surface of glioma microvasculature. Immunofluorescence and atomic force microscopy combined with immunogold labeling techniques were used to characterize and determine the position of the glioma microvasculature endothelial cell surface receptor VEGFR-2. We aimed to indirectly detect the distribution of VEGFR-2 on the cell membrane at the nanoscale level and to analyze VEGFR-2 quantitatively. Immunofluorescence imaging showed a large amount of VEGFR-2 scattered across the endothelial cell surface; atomic force microscopy imaging also showed two globular structures of different sizes scattered across the endothelial cell surface. The difference between the average diameter of the small globular structure outside the cell surface (43.67 ± 5.02 nm) and that of IgG (44.61 ± 3.19 nm) was not statistically significant (P > 0.05). The three-dimensional morphologies of the small globular structure outside the cell surface and IgG were similar. The difference between the average diameter of the large globular structure outside the cell surface (74.19 ± 9.10 nm) and that of IgG-SpA-CG (74.54 ± 15.93 nm) was also not statistically significant (P > 0.05). The three-dimensional morphologies of this large globular structure outside the cell surface and IgG-SpA-CG were similar. The total density of these two globular structures within the unit area was 92 ± 19 particles μm(2). No globular structures were seen on the cell surface in the control group. The large globular structure on the surface of glioma microvascular endothelial cells was categorized as a VEGFR-2-IgG-SpA-CG immune complex, whereas the small globular structure was categorized as a VEGFR-2-IgG immune complex. The positions of the globular structures were the same as the positions of the VEGFR-2 molecules. A large amount of VEGFR-2 was scattered across glioma microvascular endothelial cell surfaces; the receptor density was about 92 per square micron.

摘要

本研究旨在研究胶质瘤微血管内皮细胞表面 VEGFR-2 膜受体的纳米级分布和密度。采用免疫荧光和原子力显微镜结合免疫金标记技术,对胶质瘤微血管内皮细胞表面受体 VEGFR-2 进行了特征描述和定位。我们旨在间接检测细胞膜上 VEGFR-2 在纳米级水平上的分布,并对其进行定量分析。免疫荧光成像显示大量 VEGFR-2 散布在细胞表面;原子力显微镜成像也显示两个大小不同的球形结构散布在细胞表面。细胞表面外小球形结构的平均直径(43.67 ± 5.02nm)与 IgG 的平均直径(44.61 ± 3.19nm)之间的差异无统计学意义(P > 0.05)。细胞表面外小球形结构和 IgG 的三维形态相似。细胞表面外大球形结构的平均直径(74.19 ± 9.10nm)与 IgG-SpA-CG 的平均直径(74.54 ± 15.93nm)之间的差异也无统计学意义(P > 0.05)。细胞表面外大球形结构和 IgG-SpA-CG 的三维形态相似。单位面积内这两种球形结构的总密度为 92 ± 19 个颗粒 μm(2)。对照组细胞表面未见球形结构。胶质瘤微血管内皮细胞表面的大球形结构被归类为 VEGFR-2-IgG-SpA-CG 免疫复合物,而小球形结构则被归类为 VEGFR-2-IgG 免疫复合物。球形结构的位置与 VEGFR-2 分子的位置相同。大量的 VEGFR-2 散布在胶质瘤微血管内皮细胞表面;受体密度约为每平方微米 92 个。

相似文献

1
A study of the distribution and density of the VEGFR-2 receptor on glioma microvascular endothelial cell membranes.研究血管内皮生长因子受体-2(VEGFR-2)在脑胶质瘤微血管内皮细胞膜上的分布和密度。
Cell Mol Neurobiol. 2011 Jul;31(5):687-94. doi: 10.1007/s10571-011-9665-6. Epub 2011 Mar 9.
2
Characterizing nanoscale changes in the activity of VEGFR-2 on glioma microvascular endothelial cell membranes using atomic force microscopy.使用原子力显微镜表征胶质瘤微血管内皮细胞膜上VEGFR-2活性的纳米级变化。
Exp Ther Med. 2017 Feb;13(2):483-488. doi: 10.3892/etm.2016.4014. Epub 2016 Dec 29.
3
Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma.胶质瘤细胞中的血管内皮生长因子受体2(VEGFR-2)赋予PTEN基因缺陷型胶质母细胞瘤对化疗和抗血管生成治疗的抗性。
Oncotarget. 2015 Oct 13;6(31):31050-68. doi: 10.18632/oncotarget.2910.
4
Endothelial progenitor cells may inhibit apoptosis of pulmonary microvascular endothelial cells: new insights into cell therapy for pulmonary arterial hypertension.内皮祖细胞可能抑制肺微血管内皮细胞凋亡:肺动脉高压细胞治疗的新见解。
Cytotherapy. 2009;11(4):492-502. doi: 10.1080/14653240902960460.
5
Circulating endothelial progenitor cells are involved in VEGFR-2-related endothelial differentiation in glioma.循环内皮祖细胞参与胶质瘤中与血管内皮生长因子受体2(VEGFR-2)相关的内皮分化过程。
Oncol Rep. 2014 Nov;32(5):2007-14. doi: 10.3892/or.2014.3467. Epub 2014 Sep 5.
6
Glioma cells enhance endothelial progenitor cell angiogenesis via VEGFR-2, not VEGFR-1.胶质瘤细胞通过血管内皮生长因子受体2(VEGFR-2)而非血管内皮生长因子受体1(VEGFR-1)增强内皮祖细胞的血管生成。
Oncol Rep. 2008 Dec;20(6):1457-63.
7
Formation of the glomerular microvasculature is regulated by VEGFR-3.肾小球微血管的形成受 VEGFR-3 的调节。
Am J Physiol Renal Physiol. 2023 Jan 1;324(1):F91-F105. doi: 10.1152/ajprenal.00066.2022. Epub 2022 Nov 17.
8
The phosphorylation of vascular endothelial growth factor receptor-2 (VEGFR-2) by engineered surfaces with electrostatically or covalently immobilized VEGF.通过静电或共价固定血管内皮生长因子(VEGF)的工程表面使血管内皮生长因子受体-2(VEGFR-2)磷酸化。
Biomaterials. 2009 Sep;30(27):4618-28. doi: 10.1016/j.biomaterials.2009.05.030. Epub 2009 Jun 21.
9
Matrix metalloproteinase activity causes VEGFR-2 cleavage and microvascular rarefaction in rat mesentery.基质金属蛋白酶活性导致大鼠肠系膜中 VEGFR-2 的裂解和微血管稀疏。
Microcirculation. 2011 Apr;18(3):228-37. doi: 10.1111/j.1549-8719.2011.00082.x.
10
Vascular endothelial growth factor receptor 2 (VEGFR-2) plays a key role in vasculogenic mimicry formation, neovascularization and tumor initiation by Glioma stem-like cells.血管内皮生长因子受体 2(VEGFR-2)在血管生成拟态形成、Glioma 干细胞样细胞的新生血管形成和肿瘤起始中发挥关键作用。
PLoS One. 2013;8(3):e57188. doi: 10.1371/journal.pone.0057188. Epub 2013 Mar 11.

引用本文的文献

1
Anlotinib alone or in combination with bevacizumab in the treatment of recurrent high-grade glioma: a prospective single-arm, open-label phase II trial.安罗替尼单药或联合贝伐珠单抗治疗复发性高级别胶质瘤:一项前瞻性单臂、开放标签的 II 期临床试验。
BMC Cancer. 2024 Jan 2;24(1):6. doi: 10.1186/s12885-023-11776-4.
2
Characterizing nanoscale changes in the activity of VEGFR-2 on glioma microvascular endothelial cell membranes using atomic force microscopy.使用原子力显微镜表征胶质瘤微血管内皮细胞膜上VEGFR-2活性的纳米级变化。
Exp Ther Med. 2017 Feb;13(2):483-488. doi: 10.3892/etm.2016.4014. Epub 2016 Dec 29.

本文引用的文献

1
Antiangiogenic therapies for high-grade glioma.抗血管生成疗法治疗高级别脑胶质瘤。
Nat Rev Neurol. 2009 Nov;5(11):610-20. doi: 10.1038/nrneurol.2009.159. Epub 2009 Oct 13.
2
[Expression of VEGF and NGF in gliomas of human].[人胶质瘤中血管内皮生长因子和神经生长因子的表达]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2009 May;40(3):408-11.
3
Antiangiogenic therapy for high-grade gliomas.抗血管生成治疗高级别胶质瘤。
CNS Neurol Disord Drug Targets. 2009 Jun;8(3):184-94. doi: 10.2174/187152709788680706.
4
Angiogenesis and anti-angiogenic molecularly targeted therapies in malignant gliomas.恶性胶质瘤中的血管生成与抗血管生成分子靶向治疗
Oncology. 2009;77(1):1-11. doi: 10.1159/000218165. Epub 2009 May 12.
5
Assessing the cytoskeletal system and its elements in C6 glioma cells and astrocytes by atomic force microscopy.通过原子力显微镜评估C6胶质瘤细胞和星形胶质细胞中的细胞骨架系统及其成分。
Cell Mol Neurobiol. 2008 Sep;28(6):895-905. doi: 10.1007/s10571-008-9267-0. Epub 2008 Mar 4.
6
PET of vascular endothelial growth factor receptor expression.血管内皮生长因子受体表达的正电子发射断层扫描
J Nucl Med. 2006 Dec;47(12):2048-56.
7
Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis.血管内皮生长因子受体-1和受体-2在血管生成中的不同作用。
J Biochem Mol Biol. 2006 Sep 30;39(5):469-78. doi: 10.5483/bmbrep.2006.39.5.469.
8
Multi-step fibrinogen binding to the integrin (alpha)IIb(beta)3 detected using force spectroscopy.使用力谱法检测纤维蛋白原与整合素αIIbβ3的多步结合。
Biophys J. 2005 Oct;89(4):2824-34. doi: 10.1529/biophysj.105.061887. Epub 2005 Jul 22.
9
Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin.通过针对血管内皮生长因子受体-2、表皮生长因子受体和血管内皮钙黏蛋白的联合治疗抑制胶质母细胞瘤的血管生成和侵袭。
Clin Cancer Res. 2005 Jul 1;11(13):4934-40. doi: 10.1158/1078-0432.CCR-04-2270.
10
A statistical thermodynamic model applied to experimental AFM population and location data is able to quantify DNA-histone binding strength and internucleosomal interaction differences between acetylated and unacetylated nucleosomal arrays.应用于原子力显微镜(AFM)实验群体和定位数据的统计热力学模型,能够量化乙酰化和未乙酰化核小体阵列之间的DNA-组蛋白结合强度和核小体间相互作用差异。
Biophys J. 2004 Nov;87(5):3372-87. doi: 10.1529/biophysj.103.034744. Epub 2004 Sep 3.